Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Continuous Glucose Monitoring in Youth With Type 2 Diabetes

Completed

Conditions: Type 2 Diabetes

First Posted Date: 2014-11-18

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT02293577

Locations: 🇺🇸
Yale Pediatric Diabetes Research Program, New Haven, Connecticut, United States

Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Ketamine
Behavioral: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2014-11-13

Last Posted Date: 2017-03-01

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT02289248

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸
Yale Psychiatric Hospital, New Haven, Connecticut, United States

Compare the Effect of Propofol vs. "Ketofol" on Hemodynamic Stability During Induction of General Anesthesia

Phase 2

Withdrawn

Conditions: Patients With "ASA 3" Designation

Interventions: Drug: Propofol-Ketamine
Drug: Propofol

First Posted Date: 2014-11-05

Last Posted Date: 2016-12-15

Lead Sponsor: Yale University

Registration Number: NCT02282891

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Dietary Supplement: High/Low Sodium Diet

First Posted Date: 2014-11-05

Last Posted Date: 2021-04-19

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT02282878

Locations: 🇺🇸
Yale MS Center, New Haven, Connecticut, United States

Study of Postoperative Chest Tube Management

Phase 4

Completed

Conditions: Lung Resection

Interventions: Other: Reg Pressure
Other: Unreg Pressure
Other: Active Suction (Trad)
Other: Active Suction (Dig)
Other: Passive Drainage (Trad)
Other: Passive Drainage (Dig)

First Posted Date: 2014-11-04

Last Posted Date: 2020-06-26

Lead Sponsor: Yale University

Target Recruit Count: 600

Registration Number: NCT02282462

Locations: 🇺🇸
WellStar Health System - Kennestone, Marietta, Georgia, United States
🇺🇸
St. Luke's Hospital, Bethlehem, Pennsylvania, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

and more 2 locations

Investigating the Role of the Polyol Pathway in the Central Nervous System

Not Applicable

Completed

Conditions: Hyperglycemia

Interventions: Other: Brain MRS during hyperglycemic clamp
Other: Analysis of Metabolites in cerebrospinal fluid

First Posted Date: 2014-10-23

Last Posted Date: 2022-08-18

Lead Sponsor: Yale University

Target Recruit Count: 138

Registration Number: NCT02272556

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction

Phase 1

Completed

Conditions: Colon Cancer

Interventions: Drug: Omalizumab

First Posted Date: 2014-10-17

Last Posted Date: 2019-05-30

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT02266355

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

Phase 1

Completed

Conditions: Influenza
Gammopathy

Interventions: Drug: Fluzone

First Posted Date: 2014-10-17

Last Posted Date: 2016-08-25

Lead Sponsor: Yale University

Target Recruit Count: 51

Registration Number: NCT02267733

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness

Not Applicable

Completed

Conditions: Mental Health Wellness 1
Other Diagnoses, Comorbidities, and Complications | Patient
Mental Illnesses

Interventions: Behavioral: Peer whole health intervention
Behavioral: EBPs at Wellness Center

First Posted Date: 2014-10-13

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 204

Registration Number: NCT02263742

Locations: 🇺🇸
CT Mental Health Center, New Haven, Connecticut, United States
🇺🇸
Yale University Program for Recovery and Community Health, New Haven, Connecticut, United States

The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism

Phase 1

Completed

Conditions: Alcoholism

Interventions: Drug: 125 mg AZD0530
Drug: 50 mg AZD0530
Drug: Placebo

First Posted Date: 2014-10-10

Last Posted Date: 2023-02-24

Lead Sponsor: Yale University

Target Recruit Count: 49

Registration Number: NCT02262026

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy